Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceMaestro Rechargeable System
Generic Nameneuromodulator for obesity
ApplicantReshape Lifesciences, Inc.
2800 Patton Rd.
Roseville, MN 55113
PMA NumberP130019
Supplement NumberS019
Date Received12/17/2018
Decision Date02/15/2019
Withdrawal Date01/19/2021
Product Code PIM 
Advisory Committee Gastroenterology/Urology
Clinical TrialsNCT01327976
Supplement TypeNormal 180 Day Track No User Fee
Supplement Reason Postapproval Study Protocol
Expedited Review Granted? No
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
Approval of the revised protocol which includes modification to the follow-up schedule for the post-approval study (PAS) protocol.
-
-